Form 4: SOPHIA GENETICS SA: Officer Sells Shares for Tax Withholding

SOPHIA GENETICS SA reports that Chief Legal Officer Daan van Well sold shares to cover tax obligations related to vested restricted stock units, executed under a Rule 10b5-1 trading plan.

Summary

• Daan van Well, Chief Legal Officer of SOPHiA GENETICS SA, sold a total of 5,105 ordinary shares on April 6th and 7th, 2026.
• These sales were conducted to satisfy tax withholding obligations arising from the vesting of restricted stock units.
• The transactions were executed under a pre-established Rule 10b5-1 trading plan, indicating they were not discretionary.
• The sales occurred at weighted average prices, with specific ranges provided for each transaction date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly negative sentiment score, as while the sales are for tax purposes and under a 10b5-1 plan, a significant number of shares were sold by a key executive.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, which is designed to comply with insider trading regulations and provides an affirmative defense.
• The transactions were for the purpose of covering tax withholding obligations, a common and expected event for executives receiving equity compensation.

Negatives

• A significant number of shares (5,105) were sold by a key executive.
• The sales represent a reduction in the executive's direct beneficial ownership of the company's stock.

Risks

• Potential negative market perception due to a significant share sale by a senior officer, even if for tax purposes.
• The weighted average sale prices indicate a potential downward pressure on the stock price during the transaction periods.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it solely reports on past transactions.

Management Comments

• Sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
• The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for publicly traded companies, detailing changes in beneficial ownership by insiders. Such filings are crucial for investors to monitor insider activity, though sales for tax withholding under a Rule 10b5-1 plan are generally considered less indicative of negative sentiment than discretionary sales.

Stakeholder Impact

• Shareholders: May perceive insider selling negatively, potentially impacting short-term stock price, although the tax-related nature and 10b5-1 plan mitigate this concern.
• Employees: May view executive compensation structures and tax implications as standard practice.
• Management: Daan van Well's direct beneficial ownership is reduced, but the sale is a planned event for tax compliance.

Next Steps

• Monitor future Form 4 filings for any further changes in beneficial ownership by Daan van Well or other insiders.
• Observe the company's stock performance in light of this insider selling activity.

Key Dates

Keywords

SOPHIA GENETICS SA, Form 4, Insider Trading, Share Sale, Tax Withholding, Rule 10b5-1, Restricted Stock Units, Executive Compensation, Beneficial Ownership